Been here done that........... multi year bio sector run ending ?...
You da man! Jesse, I knew we could count on you! The biotech crash has finally arrived after a spectacular multi year run is ending.
So who "recovers" when the next one starts?... not the 2012-2014 speculative ones.... the ones with REVENUES.
Insmed best case next year for CF on a small scale in Europe is in jeopardy as Insmed took a risk on on a dual filing. It will be a 13 month review period.
(2016 is more probable to see some limited revenues) NTM - yet to be decided but my guess" of the FDA wanting "additional data- be it the extension trial or a new trial is tthe odds on bet.
If Arikayce gets a breaktrhu as Kitten said this am, that would bring in investors
biotech indices now sitting on 200 day moving average. Peaked one month after INSM peaked in January. INSM greatly outperformed the strong biotech index in last year, so makes me think INSM may have even farther to fall. better show its stuff now.
so, fell another 5% this morning and recovered; 200 day moving avg is 15.66. also, now at bottom of downtrending channel of past few months. this would be a time for a reversal if it's going to happen. (and, if one believes in INSM's longer term fundamentals) for a buy. i apologize in advance for attempt at rational discussion on this board.